{"id":53705,"date":"2021-07-02T12:47:57","date_gmt":"2021-07-02T12:47:57","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=75932"},"modified":"2021-07-02T12:47:57","modified_gmt":"2021-07-02T12:47:57","slug":"nyxoah-announces-pricing-of-nasdaq-public-offering","status":"publish","type":"post","link":"https:\/\/lebanonnewsgazette.com\/nyxoah-announces-pricing-of-nasdaq-public-offering\/","title":{"rendered":"Nyxoah Announces Pricing of Nasdaq Public Offering"},"content":{"rendered":"

Mont-Saint-Guibert, Belgium \u2013 July 2, 2021, 2:40pm CET \/ 8:40am ET \u2013 Nyxoah SA (Euronext Brussels\/Nasdaq: NYXH)<\/strong>\u00a0(\u201cNyxoah\u201d or the \u201cCompany\u201d), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the pricing of its initial public offering in the United States (the “Offering”) of 2,835,000 ordinary shares at a price to the public of US$\u00a030 per share for total gross proceeds of US$\u00a085.1 million before deducting underwriting discounts and commissions and estimated offering expenses.<\/p>\n

In addition, Nyxoah has granted the underwriters a 30-day option to purchase up to an additional 425,250\u00a0ordinary shares at the initial public offering price less underwriting discounts and commissions, to cover over-allotments, if any.<\/p>\n

The closing of the Offering is expected to occur on July 7, 2021, subject to the satisfaction of customary closing conditions.<\/p>\n

Nyxoah\u2019s ordinary shares are listed on Euronext Brussels under the symbol \u201cNYXH\u201d. The ordinary shares are expected to begin trading on the NASDAQ Global Market on July 2, 2021 under the same symbol.<\/p>\n

Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the offering. Degroof Petercam is acting as a co-manager.<\/p>\n

A registration statement relating to the ordinary shares was filed with the Securities and Exchange Commission (\u201cSEC\u201d) and declared effective on June 30, 2021. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction.<\/p>\n

The offering of ordinary shares was made only by means of a prospectus. When available, a copy of the final prospectus can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at\u00a0prospectus@psc.com<\/a>, or by phone at (800) 747-3924; Stifel, Nicolaus\u00a0&\u00a0Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720, or by email at\u00a0syndprospectus@stifel.com<\/a>; or Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; email:\u00a0prospectus@cantor.com<\/a>.<\/p>\n

Forward-Looking Statements<\/strong>
\nThis press release includes certain disclosures that contain \u201cforward-looking statements,\u201d including, without limitation, statements regarding the closing of the offering. Forward-looking statements are based on Nyxoah\u2019s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and could cause actual results to differ. Forward-looking statements contained in this announcement are made as of this date, and Nyxoah undertakes no duty to update such information except as required under applicable law.<\/p>\n

IMPORTANT INFORMATION<\/strong>
\nNo public offering will be made and no one has taken any action that would, or is intended to, permit a public offering in any country or jurisdiction, other than the United States, where any such action is required, including in Belgium. Belgian investors, other than qualified investors within the meaning of the Belgian Act of 11 July 2018 on the public offering of securities and the admission of securities to be traded on a regulated market, will not be eligible to participate in the offering (whether in Belgium or elsewhere). The transaction to which this press release relates will only be available to, and will be engaged in only with, in member states of the European Economic Area, persons falling within the meaning of Article 2(e) of Regulation (EU) 2017\/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “Prospectus Regulation”), and in the United Kingdom, investment professionals falling within article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), persons falling within article 49 (2), (a) to (d) of the Order and other persons to whom it may lawfully be communicated. A listing prospectus will be prepared by Nyxoah in accordance with Article 3 of the Prospectus Regulation for the purpose of having the new ordinary shares, issued pursuant to the Offering or (as the case may be) the exercise by the underwriters of their 30-day option to purchase additional ordinary shares, admitted to trading on Euronext Brussels.<\/p>\n

Contacts:<\/strong>
\nNyxoah<\/strong>
\nFabian Suarez, Chief Financial Officer
\nfabian.suarez@nyxoah.com<\/u><\/a>
\n+32 10 22 24 55<\/p>\n

Gilmartin Group<\/strong>
\nVivian Cervantes
\nIR@nyxoah.com<\/u><\/a><\/p>\n

Attachment<\/strong><\/p>\n